| Figure 1‑1: Anesthesia, Respiratory and Sleep Management Device Market Share Ranking by Segment, U.S., 2022 (1 of 2) |
| Figure 1‑2: Anesthesia, Respiratory and Sleep Management Device Market Share Ranking by Segment, U.S., 2022 (2 of 2) |
| Figure 1‑3: Companies Researched in This Report (1 of 2) |
| Figure 1‑4: Companies Researched in This Report (2 of 2) |
| Figure 1‑5: Factors Impacting the Anesthesia, Respiratory and Sleep Management Device Market by Segment, U.S. (1 of 2) |
| Figure 1‑6: Factors Impacting the Anesthesia, Respiratory and Sleep Management Device Market by Segment, U.S. (2 of 2) |
| Figure 1‑7: Recent Events in the Anesthesia, Respiratory and Sleep Management Device Market, U.S., 2019 – 2023 (1 of 2) |
| Figure 1‑8: Recent Events in the Anesthesia, Respiratory and Sleep Management Device Market, U.S., 2019 – 2023 (2 of 2) |
| Figure 1‑9: Anesthesia, Respiratory and Sleep Management Device Markets Covered (1 of 3) |
| Figure 1‑10: Anesthesia, Respiratory and Sleep Management Device Markets Covered (2 of 3) |
| Figure 1‑11: Anesthesia, Respiratory and Sleep Management Device Markets Covered (3 of 3) |
| Figure 1‑12: Key Report Updates |
| Figure 1‑13: Version History |
| Figure 2‑1: Anesthesia, Respiratory and Sleep Management Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑2: Anesthesia, Respiratory and Sleep Management Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 2‑3: Anesthesia, Respiratory and Sleep Management Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑4: Anesthesia, Respiratory and Sleep Management Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 2‑5: Anesthesia, Respiratory and Sleep Management Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑6: Anesthesia, Respiratory and Sleep Management Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 4‑1: Anesthesia Delivery Unit by Company |
| Figure 4‑2: Anesthesia Monitor by Company |
| Figure 4‑3: Anesthesia Information Management System by Company |
| Figure 4‑4: Anesthesia Disposables by Company (1 of 3) |
| Figure 4‑5: Anesthesia Disposables by Company (2 of 3) |
| Figure 4‑6: Anesthesia Disposables by Company (3 of 3) |
| Figure 4‑7: Ventilators by Company (1 of 2) |
| Figure 4‑8: Ventilators by Company (2 of 2) |
| Figure 4‑9: Nebulizers by Company |
| Figure 4‑10: Respiratory Disposables by Company (1 of 4) |
| Figure 4‑11: Respiratory Disposables by Company (2 of 4) |
| Figure 4‑12: Respiratory Disposables by Company (3 of 4) |
| Figure 4‑13: Respiratory Disposables by Company (4 of 4) |
| Figure 4‑14: Oxygen Therapy Devices by Company (1 of 3) |
| Figure 4‑15: Oxygen Therapy Devices by Company (2 of 3) |
| Figure 4‑16: Oxygen Therapy Devices by Company (3 of 3) |
| Figure 4‑17: Therapeutic Sleep Management Devices by Company (1 of 2) |
| Figure 4‑18: Therapeutic Sleep Management Devices by Company (2 of 2) |
| Figure 4‑19: Sleep Diagnostic Devices by Company (1 of 2) |
| Figure 4‑20: Sleep Diagnostic Devices by Company (2 of 2) |
| Figure 4‑21: Class 2 Device Recall GE Healthcare Avance and Aisys |
| Figure 4‑22: Class 1 Device Recall GE Healthcare Aisys and Avance |
| Figure 4‑23: Class 2 Device Recall Fabius MRI |
| Figure 4‑24: Class 2 Device Recall Aestiva 7900 |
| Figure 4‑25: Class 2 Device Recall Aisys CS2 |
| Figure 4‑26: Class 2 Device Recall Aestiva MRI |
| Figure 4‑27: Class 1 Device Recall Carestation 620/650/650c A1 |
| Figure 4‑28: Class 2 Device Recall Philips EarlyVue VS30 Vitals monitor |
| Figure 4‑29: Class 2 Device Recall Draeger Infinity M300 |
| Figure 4‑30: Class 2 Device Recall Draeger Infinity CentralStation |
| Figure 4‑31: Class 2 Device Recall GE |
| Figure 4‑32: Class 2 Device Recall IntelliVue MX40 Patient Monitor |
| Figure 4‑33: Class 2 Device Recall Mindray BeneVision Distributed Monitoring System (DMS) |
| Figure 4‑34: Class 2 Device Recall Philips IntelliVue X2 |
| Figure 4‑35: Class 2 Device Recall Philips IntelliVue MP2 |
| Figure 4‑36: Class 2 Device Recall IntelliVue |
| Figure 4‑37: Class 2 Device Recall IntelliVue MX800 |
| Figure 4‑38: Class 2 Device Recall IntelliVue |
| Figure 4‑39: Class 2 Device Recall Philips SureSigns |
| Figure 4‑40: Class 1 Device Recall CARESCAPE Respiratory Module EsCOVX |
| Figure 4‑41: Class 2 Device Recall Rosebud Vital Signs Monitor |
| Figure 4‑42: Class 1 Device Recall VentStar Coax |
| Figure 4‑43: Class 2 Device Recall Intersurgical Laryngeal Mask |
| Figure 4‑44: Class 2 Device Recall RUSCH Endotracheal Tube oral/nasal Magill, High Volume, Low Pressure Cuff |
| Figure 4‑45: Class 2 Device Recall VentStar |
| Figure 4‑46: Class 2 Device Recall Smoothbore breathing system with exhalation port 22 mm |
| Figure 4‑47: Class 1 Device Recall Oxylog 3000 Plus Emergency and Transport Ventilator |
| Figure 4‑48: Class 2 Device Recall Vyaire MEDICAL |
| Figure 4‑49: Class 1 Device Recall Trilogy EV300 |
| Figure 4‑50: Class 1 Device Recall Philips Respironics V680 Plus Ventilator |
| Figure 4‑51: Class 2 Device Recall Draeger |
| Figure 4‑52: Class 1 Device Recall Bellavista |
| Figure 4‑53: Class 2 Device Recall Draeger |
| Figure 4‑54: Class 1 Device Recall Philips Respironics E30 with Humidifier |
| Figure 4‑55: Class 1 Device Recall Trilogy 100, Trilogy 200, Garbin Plus, Aeris, LifeVent Continuous Ventilators |
| Figure 4‑56: Class 2 Device Recall Evita V800 Ventilator |
| Figure 4‑57: Class 2 Device Recall Evita V600 Ventilator |
| Figure 4‑58: Class 2 Device Recall Babylog VN600 Ventilator |
| Figure 4‑59: Class 2 Device Recall Babylog VN800 Ventilator |
| Figure 4‑60: Class 2 Device Recall Draeger |
| Figure 4‑61: Class 2 Device Recall Servo-i |
| Figure 4‑62: Class 1 Device Recall Trilogy EVO |
| Figure 4‑63: Class 1 Device Recall Stellar 150 |
| Figure 4‑64: Class 2 Device Recall bellavista Ventilator |
| Figure 4‑65: Class 2 Device Recall Oral/Nasal Tracheal Tube |
| Figure 4‑66: Class 2 Device Recall OxyMask |
| Figure 4‑67: Class 2 Device Recall Bivona Cuffless Adjustable Neck Flange Hyperflex Pediatric Tracheostomy Tubes |
| Figure 4‑68: Class 2 Device Recall RUSCH LASERTUBE |
| Figure 4‑69: Class 2 Device Recall Bivona Tracheostomy Tubes |
| Figure 4‑70: Class 1 Device Recall Hudson RCI Sheridan LTS |
| Figure 4‑71: Class 2 Device Recall Tube, Tracheal Bronchial |
| Figure 4‑72: Class 2 Device Recall RUSCH LASERTUBE |
| Figure 4‑73: Class 1 Device Recall HUDSON RDI NEONATAL ConchaSmart Breathing Circuit |
| Figure 4‑74: Class 1 Device Recall Hudson RCI Sheridan LTS |
| Figure 4‑75: Class 2 Device Recall Philips Respironics V60 Ventilator |
| Figure 4‑76: Class 2 Device Recall 1025 SERIES OXYGEN CONCENTRATOR |
| Figure 4‑77: Class 2 Device Recall DeVilbiss |
| Figure 4‑78: Class 2 Device Recall Drive DeVilbiss iGo 2 Portable Oxygen Concentrator |
| Figure 4‑79: Class 3 Device Recall Invacare Platinum 5NXG Oxygen Concentrator |
| Figure 4‑80: Class 2 Device Recall FreeStyle Comfort |
| Figure 4‑81: Class 1 Device Recall Philips Respironics V60 Ventilator |
| Figure 4‑82: Class 1 Device Recall Respironics Model V60 Plus Ventilator |
| Figure 4‑83: Class 2 Device Recall Invacare PerfectO2 V Oxygen Concentrator |
| Figure 4‑84: Class 2 Device Recall FreeStyle Comfort Oxygen Concentrator |
| Figure 4‑85: Class 2 Device Recall SAROS Oxygen System Model 3000 |
| Figure 4‑86: Class 1 Device Recall DreamStation1 (Uno Remediated Device) |
| Figure 4‑87: Class 1 Device Recall DreamWear |
| Figure 4‑88: Class 1 Device Recall DreamWisp |
| Figure 4‑89: Class 1 Device Recall ASeries BiPAP A40, and ASeries BiPAP A30 Continuous Ventilator |
| Figure 4‑90: Class 1 Device Recall DreamStation ASV, DreamStation ST, AVAPS, SystemOne ASV4, CSeries ASV, CSeries S/T and AVAPS, Omni |
| Figure 4‑91: Class 1 Device Recall DreamStation, DreamStation Go, Dorma 400, Dorma 500, and REMstar SE Auto |
| Figure 4‑92: Class 2 Device Recall BiPAP A40 System Silver, JP |
| Figure 4‑93: Class 2 Device Recall BiPAP V30 Auto System/BiPAP V30 Auto Ventilator, Domestic |
| Figure 4‑94: Class 2 Device Recall PSG1100 Sleep Diagnostic System |
| Figure 4‑95: The Incidence of Artifacts in the Anesthesia Information Management System Database |
| Figure 4‑96: I-gel vs Ambu AuraGain in Laparoscopic Gynecological Surgery |
| Figure 4‑97: Comparation of Proseal Laryngeal Mask Airway with Flexible Laryngeal Airway Mask |
| Figure 4‑98: Effect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) Adults |
| Figure 4‑99: Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients |
| Figure 4‑100: Evaluation of the Ambu® AuraGain in Ambulatory Surgery |
| Figure 4‑101: Effect of Heated Breathing Circuit on Intraoperative Core Temperature and Systemic Inflammation after Brain Surgery: A Prospective Randomized Study |
| Figure 4‑102: Heated Circuit on Sore Throat |
| Figure 4‑103: The Effect of Reinforced Endotracheal Tube on Post-operative Hoarseness Undergoing Thyroidectomy |
| Figure 4‑104: Comparison of Endotracheal Intubation Over the Aintree with Fiberoptic Bronchoskop Via the I-gel and LMA Protector |
| Figure 4‑105: Pre-hospital Ventilation Clinical Study |
| Figure 4‑106: Comparison of Gas Exchange Between Two Invasive Mechanical Ventilation Modes in Children (CoCO2) |
| Figure 4‑107: Post Market, Prospective Multicenter Observational Study of the Safety and Performance of bellavista Ventilator |
| Figure 4‑108: Use of Airway Pressure Release Ventilation in Morbidly Obese Patients Undergoing Open Heart Surgery |
| Figure 4‑109: NPPV vs IPPV in Severe Chronic Obstructive Pulmonary Disease Exacerbation |
| Figure 4‑110: Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients with Heart Failure |
| Figure 4‑111: Wean Early with HFNCO vs NPPV in Patients with AHRF |
| Figure 4‑112: SuperNO2VA™ and General Anesthesia Postoperative Care |
| Figure 4‑113: Jet or Vibrating Mesh Nebulisation for Secretion Management in ICU |
| Figure 4‑114: The Effect of Toy-Type Nebulizer on Fear and Anxiety in Children Receiving Inhaler Treatment |
| Figure 4‑115: Trial in Non-cystic Fibrosis Bronchiectasis Patients with Chronic Lung Infections Treated with Colistimethate Sodium (PROMIS-2) |
| Figure 4‑116: A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients with Stable COPD |
| Figure 4‑117: SpeakFree Heat and Moisture Exchanger (HME) (SPEAKFREE) |
| Figure 4‑118: Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients |
| Figure 4‑119: The Effects Incentive Spirometry Use in Coronary Artery Bypass Surgery |
| Figure 4‑120: Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants |
| Figure 4‑121: Comparison of High-Flow Nasal Cannula Oxygen Application and Classic Nasal Cannula Oxygen Application |
| Figure 4‑122: Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children with Bronchiolitis |
| Figure 4‑123: Non Invasive Mechanical Ventilation VERSUS Oxygen MASK |
| Figure 4‑124: Portable Oxygen Concentrator in Non-hospitalized Patients with Chronic Heart Failure |
| Figure 4‑125: Efficacy of High Flow Nasal Oxygen Therapy Started in the Emergency Room Versus Conventional Oxygen Therapy in Patients with Acute Hypoxemic Respiratory Distress |
| Figure 4‑126: Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study |
| Figure 4‑127: Nasal Oxygen Therapy after Cardiac Surgery (NOTACS) |
| Figure 4‑128: Automatic Oxygen Control for Reducing Extremes of Oxygen Saturation (AreOS): A Randomised Control Trial (AreOS) |
| Figure 4‑129: Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN) |
| Figure 4‑130: Usability Evaluation of a Portable Oxygen Concentrator |
| Figure 4‑131: A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
| Figure 4‑132: Long-Term Observation of PAP-Therapy with Telemonitoring: Telemedicine Registry TelePAP (TelePAP) |
| Figure 4‑133: 3D Printing of Positive Airway Pressure (PAP) Therapy Masks: A Single Site Pilot and Feasibility Study |
| Figure 4‑134: Effects of Continuous Positive Airway Pressure Therapy Withdrawal in Patients with Obstructive Sleep Apnea: A Randomized Trial |
| Figure 4‑135: Efficacy and Safety of keepMED Positive Airway Pressure Device in Patients with Obstructive Sleep Apnea |
| Figure 4‑136: A Prospective Multicenter Registry of Patients with Sleep Disordered Breathing Treated with DreamStation BiPAP autoSV (autoSVREGDE) |
| Figure 4‑137: Auto-PAP Therapy for Improved Fetal Growth |
| Figure 4‑138: Obstructive Sleep Apnea Syndrome: Evaluation of the Efficacy of Sleepinnov© (Spiri+) Continuous Positive Airway Pressure Device (Spiri+) |
| Figure 4‑139: Therapy Adherence Management in Veterans |
| Figure 4‑140: Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome (C-SAS) |
| Figure 4‑141: Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy |
| Figure 4‑142: European Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV) |
| Figure 4‑143: Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone: Impact of APAP vs CPAP |
| Figure 4‑144: CPAP for OSA on Myocardial Salvage after pPCI for STEMI Patients |
| Figure 4‑145: Home Apnea Testing in CHildren Trial (HATCH) |
| Figure 4‑146: Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis |
| Figure 4‑147: Comparative Assessment of Compumedics Somfit Sleep Monitoring Device |
| Figure 4‑148: A Validation Study of the NightOwl Home Sleep Apnea Test |
| Figure 4‑149: Validation of ApneaLink Air Home Sleep Testing in the Diagnosis of Obstructive Sleep Apnea in Adolescent Children |
| Figure 4‑150: ApneaLink Air Home Sleep Testing (HST) Device Validation Study |
| Figure 5‑1: Anesthesia, Respiratory and Sleep Management Device Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 5‑2: Anesthesia, Respiratory and Sleep Management Device Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 5‑3: Leading Competitors, Anesthesia, Respiratory and Sleep Management Device Market, U.S., 2022 (1 of 2) |
| Figure 5‑4: Leading Competitors, Anesthesia, Respiratory and Sleep Management Device Market, U.S., 2022 (2 of 2) |
| Figure 5‑5: SWOT Analysis, Ambu |
| Figure 5‑6: SWOT Analysis, Dräger |
| Figure 5‑7: SWOT Analysis, EPIC |
| Figure 5‑8: SWOT Analysis, Fisher & Paykel |
| Figure 5‑9: SWOT Analysis, GE Healthcare (1 of 2) |
| Figure 5‑10: SWOT Analysis, GE Healthcare (2 of 2) |
| Figure 5‑11: SWOT Analysis, Inogen |
| Figure 5‑12: SWOT Analysis, Medtronic |
| Figure 5‑13: SWOT Analysis, Omron |
| Figure 5‑14: SWOT Analysis, Philips |
| Figure 5‑15: SWOT Analysis, ResMed |
| Figure 5‑16: SWOT Analysis, Teleflex |
| Figure 5‑17: SWOT Analysis, Vyaire |
| Figure 6‑1: Anesthesia Delivery Unit Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 6‑2: Total Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑3: Hospital Operating Room Anesthesia Delivery Unit Market by Segment, U.S., 2019 – 2029 |
| Figure 6‑4: Total Hospital Operating Room Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑5: High-Complexity Hospital Operating Room Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑6: Low-Complexity Hospital Operating Room Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑7: Other Hospital Suite Anesthesia Delivery Unit Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 6‑8: Total Other Hospital Suite Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑9: MRI Suite Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑10: Obstetric Suite Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑11: Other/Alternate Suite Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑12: Ambulatory Surgery Center Anesthesia Delivery Unit Market by Segment, U.S., 2019 – 2029 |
| Figure 6‑13: Total Ambulatory Surgery Center Anesthesia Delivery Unit Market by Segment, U.S., 2019 – 2029 |
| Figure 6‑14: New Ambulatory Surgery Center Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑15: Refurbished Ambulatory Surgery Center Anesthesia Delivery Unit Market, U.S., 2019 – 2029 |
| Figure 6‑16: Leading Competitors, Anesthesia Delivery Unit Market, U.S., 2022 |
| Figure 7‑1: Anesthesia Monitor Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑2: Total Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑3: Hospital Monitor Market by Segment, U.S., 2019 – 2029 |
| Figure 7‑4: Total Hospital Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑5: Hospital Preoperative Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑6: Hospital OR Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑7: Hospital Post-Anesthesia Care Unit Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑8: Hospital Obstetric Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑9: Ambulatory Surgery Center Monitor Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑10: Total Ambulatory Surgery Center Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑11: Ambulatory Surgery Center Preoperative Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑12: Ambulatory Surgery Center Operating Room Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑13: Ambulatory Surgery Center Post-Anesthesia Care Unit Anesthesia Monitor Market, U.S., 2019 – 2029 |
| Figure 7‑14: Leading Competitors, Anesthesia Monitor Market, U.S., 2022 |
| Figure 8‑1: Anesthesia Information Management System Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑2: Total Anesthesia Information Management System Market, U.S., 2019 – 2029 |
| Figure 8‑3: Hospital Anesthesia Information Management System Market, U.S., 2019 – 2029 |
| Figure 8‑4: ASC Anesthesia Information Management System Market, U.S., 2019 – 2029 |
| Figure 8‑5: Leading Competitors, Anesthesia Information Management System Market, U.S., 2022 |
| Figure 9‑1: Anesthesia Disposables Market by Segment, U.S., 2019 – 2029 |
| Figure 9‑2: Total Anesthesia Disposables Market, U.S., 2019 – 2029 |
| Figure 9‑3: Anesthesia Circuit Market, U.S., 2019 – 2029 |
| Figure 9‑4: Anesthesia Mask Market, U.S., 2019 – 2029 |
| Figure 9‑5: Endotracheal Tube Market, U.S., 2019 – 2029 |
| Figure 9‑6: Laryngeal Mask Market by Segment, U.S., 2019 – 2029 |
| Figure 9‑7: Total Laryngeal Mask Market, U.S., 2019 – 2029 |
| Figure 9‑8: Disposable Laryngeal Mask Market, U.S., 2019 – 2029 |
| Figure 9‑9: Reusable Laryngeal Mask Market, U.S., 2019 – 2029 |
| Figure 9‑10: Leading Competitors, Anesthesia Disposables Market, U.S., 2022 |
| Figure 10‑1: Ventilator Market by Segment, U.S., 2019 – 2029 |
| Figure 10‑2: Total Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑3: Acute Care Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑4: Sub-Acute Care Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑5: Home Care Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑6: Neonatal Ventilator Market by Segment, U.S., 2019 – 2029 |
| Figure 10‑7: Total Neonatal Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑8: Dedicated Neonatal Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑9: High-Frequency Neonatal Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑10: Non-Invasive Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑11: Emergency Transport Ventilator Market, U.S., 2019 – 2029 |
| Figure 10‑12: Ventilator Market, Unit Analysis, U.S., 2019 – 2029 |
| Figure 10‑13: Leading Competitors, Ventilator Market, U.S., 2022 |
| Figure 11‑1: Nebulizer Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 11‑2: Total Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑3: Compressor/Jet Nebulizer Market by Segment, U.S., 2019 – 2029 |
| Figure 11‑4: Total Compressor/Jet Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑5: Stationary Compressor/Jet Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑6: Portable Compressor/Jet Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑7: Vibrating Nebulizer Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 11‑8: Total Vibrating Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑9: Ultrasonic Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑10: Vibrating Mesh Nebulizer Market, U.S., 2019 – 2029 |
| Figure 11‑11: Leading Competitors, Nebulizer Market, U.S., 2022 |
| Figure 12‑1: Respiratory Disposables Market by Segment, U.S., 2019 – 2029 |
| Figure 12‑2: Total Respiratory Disposables Market, U.S., 2019 – 2029 |
| Figure 12‑3: Oxygen Cannula Market by Segment, U.S., 2019 – 2029 |
| Figure 12‑4: Total Oxygen Cannula Market, U.S., 2019 – 2029 |
| Figure 12‑5: Low-Flow Oxygen Cannula Market, U.S., 2019 – 2029 |
| Figure 12‑6: High-Flow Oxygen Cannula Market, U.S., 2019 – 2029 |
| Figure 12‑7: Oxygen Mask Market by Segment, U.S., 2019 – 2029 |
| Figure 12‑8: Total Oxygen Mask Market, U.S., 2019 – 2029 |
| Figure 12‑9: Normal Interface Oxygen Mask Market, U.S., 2019 – 2029 |
| Figure 12‑10: Non-Invasive Interface Oxygen Mask Market, U.S., 2019 – 2029 |
| Figure 12‑11: Tracheostomy Tube Market, U.S., 2019 – 2029 |
| Figure 12‑12: Resuscitator Market, U.S., 2019 – 2029 |
| Figure 12‑13: Incentive Spirometer Market, U.S., 2019 – 2029 |
| Figure 12‑14: Heat and Moisture Exchanger Market, U.S., 2019 – 2029 |
| Figure 12‑15: Leading Competitors, Respiratory Disposables Market, U.S., 2022 |
| Figure 12‑16: Leading Competitors, Oxygen Cannula Market, U.S., 2022 |
| Figure 12‑17: Leading Competitors, Oxygen Mask Market, U.S., 2022 |
| Figure 13‑1: Oxygen Therapy Market by Segment, U.S., 2019 – 2029 |
| Figure 13‑2: Oxygen Concentrator Market by Segment, U.S., 2019 – 2029 |
| Figure 13‑3: Total Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑4: Stationary Oxygen Concentrator Market by Segment, U.S., 2019 – 2029 |
| Figure 13‑5: Stationary Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑6: Standard Stationary Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑7: High-Flow Stationary Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑8: Ambulatory Oxygen Concentrator Market by Segment, U.S., 2019 – 2029 |
| Figure 13‑9: Ambulatory Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑10: Ambulatory Transportable Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑11: Ambulatory Portable Oxygen Concentrator Market, U.S., 2019 – 2029 |
| Figure 13‑12: Transfilling Device Market, U.S., 2019 – 2029 |
| Figure 13‑13: Aluminum Medical Oxygen Cylinder Market by Segment, U.S., 2019 – 2029 |
| Figure 13‑14: Aluminum Medical Oxygen Cylinder Market, U.S., 2019 – 2029 |
| Figure 13‑15: Ambulatory Aluminum Medical Oxygen Cylinder Market, U.S., 2019 – 2029 |
| Figure 13‑16: Backup Aluminum Medical Oxygen Cylinder Market, U.S., 2019 – 2029 |
| Figure 13‑17: Medical Oxygen Regulator Market, U.S., 2019 – 2029 |
| Figure 13‑18: Oxygen Conserver Market by Segment, U.S., 2019 – 2029 |
| Figure 13‑19: Total Oxygen Conserver Market, U.S., 2019 – 2029 |
| Figure 13‑20: Pneumatic Oxygen Conserver Market, U.S., 2019 – 2029 |
| Figure 13‑21: Electronic Oxygen Conserver Market, U.S., 2019 – 2029 |
| Figure 13‑22: Total High-Flow Nasal Therapy Device Market, U.S., 2019 – 2029 |
| Figure 13‑23: High-Flow Nasal Therapy Device Market Unit Analysis, U.S., 2019 – 2029 |
| Figure 13‑24: Leading Competitors, Oxygen Therapy Market, U.S., 2022 |
| Figure 13‑25: Leading Competitors, Oxygen Concentrator Market, U.S., 2022 |
| Figure 13‑26: Leading Competitors, Oxygen Conserver Market, U.S., 2022 |
| Figure 14‑1: Therapeutic Obstructive Sleep Apnea Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 14‑2: Positive Airway Pressure Device Market by Segment, U.S., 2019 – 2029 |
| Figure 14‑3: Total Positive Airway Pressure Device Market, U.S., 2019 – 2029 |
| Figure 14‑4: Continuous Positive Airway Pressure Device Market, U.S., 2019 – 2029 |
| Figure 14‑5: Auto-Titrating Positive Airway Pressure Device Market, U.S., 2019 – 2029 |
| Figure 14‑6: Bi-Level Positive Airway Pressure Device Market, U.S., 2019 – 2029 |
| Figure 14‑7: Sleep Therapy Interface Market by Segment, U.S., 2019 – 2029 |
| Figure 14‑8: Total Sleep Therapy Interface Market, U.S., 2019 – 2029 |
| Figure 14‑9: Nasal Mask Market, U.S., 2019 – 2029 |
| Figure 14‑10: Full-Face Mask Market, U.S., 2019 – 2029 |
| Figure 14‑11: Nasal Pillow/Alternative Interface Market, U.S., 2019 – 2029 |
| Figure 14‑12: Leading Competitors, Therapeutic Obstructive Sleep Apnea Device Market, U.S., 2022 |
| Figure 15‑1: Sleep Diagnostic Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 15‑2: Type I Device Market, U.S., 2019 – 2029 |
| Figure 15‑3: Type II Device Market, U.S., 2019 – 2029 |
| Figure 15‑4: Type III Device Market, U.S., 2019 – 2029 |
| Figure 15‑5: Type IV Device Market, U.S., 2019 – 2029 |
| Figure 15‑6: Leading Competitors, Sleep Diagnostic Device Market, U.S., 2022 |
The anesthesia, respiratory, and sleep apnea (ARS) market is being positively influenced by ongoing demographic shifts in the United States. With the baby boomer generation forming the largest segment due to the decline in birth rates since 1950, coupled with an increasing obesity rate of around 42%, respiratory and sleep issues are growing. These factors are linked to more surgeries, creating a rising demand for anesthesia. By 2030, over 70 million people aged 50 and above are projected in the U.S., with almost half the population being obese. Consequently, the need for ARS products is set to rise, driving market expansion.
